Stevens-Johnson syndrome induced by acetazolamide

J Dermatol. 2011 Mar;38(3):272-5. doi: 10.1111/j.1346-8138.2010.00921.x. Epub 2010 Dec 13.

Abstract

Acetazolamide is a sulfonamide derivative and carbonic anhydrase inhibitor used to lower intraocular pressure in glaucomatous patients. Stevens-Johnson syndrome (SJS) toxic epidermal necrolysis (TEN) associated with acetazolamide treatment has been diagnosed in Japanese, Japanese-American and Indian patients. Herein, we report the second Korean case of SJS-TEN associated with acetazolamide treatment. The result of human leukocyte antigen (HLA) typing of our patient was positive for HLA-B59. According to recent research, HLA-B59 has been detected in SJS caused by metazolamide, which is analogous to acetazolamide. This suggests a possible relationship between genetic background and SJS-TEN-associated acetazolamide treatment. Theretofore, acetazolamide should be prescribed to Korean patients with the same discreet caution.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Acetazolamide / adverse effects*
  • Adult
  • Asian People / genetics*
  • Carbonic Anhydrase Inhibitors / adverse effects*
  • Female
  • HLA-B Antigens / genetics
  • Humans
  • Stevens-Johnson Syndrome / chemically induced*
  • Stevens-Johnson Syndrome / diagnosis
  • Stevens-Johnson Syndrome / ethnology*
  • Stevens-Johnson Syndrome / genetics

Substances

  • Carbonic Anhydrase Inhibitors
  • HLA-B Antigens
  • HLA-B59 antigen
  • Acetazolamide